Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Assess which option is safer for your needs—software or hardware wallets—by weighing security risks, accessibility, and practical safeguards.
21,982 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
BlinkEx unveils a security-first crypto exchange as traders grow wary of outages and freezing assets. The launch aims...
A new browser extension puts AI agents in the driver's seat without exposing your data. Learn how Kimi WebBridge Lets...
Big-money buyers are moving into Bitcoin despite a rough patch. This article explains why institutional investors buy...
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
Robinhood accelerates its blockchain push to compete with Coinbase, while Base narrows its focus to trading, payments...
A legal clash over reverse keyword warrants puts your google search history at the center of a widening privacy debat...
A weekend missile strike challenges Dubai’s safe-haven status, triggering fresh volatility in energy, equities, and t...
As regulators tighten age-verification rules and privacy protections, social media companies fighting to curb underag...
AI misinfo is not just a tech issue—it's a real-world risk that can touch markets, portfolios, and lives. This articl...
Former President Trump floated easing oil sanctions and hinted the Iran conflict could wrap up soon, sending ripples ...
Meta ends end-to-end encryption on Instagram direct messages, signaling a shift in privacy promises. TikTok counters ...